The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer
The Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer and the Medical Care Cost in Iijima Town
Sponsor: Showa Inan General Hospital
A observational or N/A phase clinical study on Eradication and Gastric Cancer, this trial is completed. The trial is conducted by Showa Inan General Hospital and has accumulated 17 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
17 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Feb 2022 — Mar 2022 [monthly]
Active Not Recruiting
-
Dec 2021 — Feb 2022 [monthly]
Active Not Recruiting
▶ Show 12 earlier versions
-
Oct 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Feb 2021 — Oct 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Apr 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Nov 2019 — Apr 2020 [monthly]
Active Not Recruiting
-
Feb 2019 — Nov 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Sep 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Showa Inan General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .